Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Chemical/toxin
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 1
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Brown Fat as Therapeutic Strategy for Obesity and Associated Metabolic Diseases Via Functional/Nutraceutical Approach - Molecular Mechanisms of Pentacyclic Triterpenes (BRACE), maslinic acid
Diabetes · Brown Adipose Tissue
Enrolment: 50 · Results not recorded
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseChemical/toxinSKH1 hairless mice; fertilised hen eggs for the chorioallantoic membrane assayFemaleTopical application of hydrogel to the ear; topical application onto the chorioallantoic membrane inside a plastic ringEM2 1% hydrogel; zinc chloride 1% and 5% hydrogels; EM2 1%…30 min after topical application of the TPA solution
Model: Acute ear inflammation induced by topical application of 20 ul per ear of 15 nM 12-O-tetradecanoylphorbol-13-acetate in acetone under sevoflurane anaesthesia; separately, the chick chorioallantoic membrane assay from embryonic day 8 to day 12 to assess tolerability and normal angiogenesis
EM2 1% hydrogel produced only a mild reduction in TPA-induced ear oedema and inflammatory infiltrate, with neutrophils diffusely distributed, moderate interstitial oedema and mast cell numbers similar to control. Zinc chloride hydrogels alone gave a mild reduction at 1% and a moderate anti-inflamma…
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.